Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT06936449 · ClinicalTrials.gov registry record
Long-term Follow-up of a Cochlear Implant With Dexamethasone Eluting Electrode Array
A clinical trial of Sensorineural Hearing Loss and Bilateral Hearing Loss, sponsored by Cochlear.
- Recruiting
- Registry status
- 19
- Enrollment target
- 3
- Study locations
NCT06936449: Recruiting study of Sensorineural Hearing Loss and Bilateral Hearing Loss, sponsored by Cochlear.
NCT06936449 is a study of Sensorineural Hearing Loss and Bilateral Hearing Loss that is actively recruiting participants, run by Cochlear. The registered enrollment target is 19 participants, below the 129-participant average among 13 other Sensorineural Hearing Loss trials with a reported enrollment target (85% lower). The trial reports 3 study locations across 3 states. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT06936449, a study of Sensorineural Hearing Loss and Bilateral Hearing Loss, is actively recruiting participants, sponsored by Cochlear.
- RECRUITING
- Registry status
- 19 participants
- Enrollment target
- 3
- Study locations
Study Summary
A long-term follow-up of Cochlear's cochlear implant electrode array which passively elutes dexamethasone for a defined period of time to help reduce inflammatory responses.
Conditions Studied
Interventions
- DEVICE CI632D
- DEVICE CI632
Study Locations (3)
Colorado
- Rocky Mountain Ear Center - Englewood
Iowa
- University of Iowa - Iowa City
Ohio
- University Hospitals Cleveland - Cleveland
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 19 participants |
| Start Date | 2025-05-05 |
| Est. Completion | 2028-03 |
What NCT06936449 shows while recruiting
NCT06936449 is an observational study that tracks outcomes without assigning an intervention. The registry caps enrollment at 19 participants, a relatively small participant target, below the 129-participant average among 13 other Sensorineural Hearing Loss trials with a reported enrollment target (85% lower).
The record links to 2 conditions, with Sensorineural Hearing Loss appearing as the primary indexed condition, and to 2 interventions - of which CI632D is the first listed.
NCT06936449 reports a single indexed study location in Colorado, Iowa, Ohio.
Frequently Asked Questions
What is clinical trial NCT06936449 about?
NCT06936449 is a clinical study titled "Long-term Follow-up of a Cochlear Implant With Dexamethasone Eluting Electrode Array". A long-term follow-up of Cochlear's cochlear implant electrode array which passively elutes dexamethasone for a defined period of time to help reduce inflammatory responses.
What is the current status of trial NCT06936449?
This trial is currently recruiting. The enrollment target is 19 participants. The study started on 2025-05-05. Estimated completion is 2028-03.
What conditions does trial NCT06936449 study?
This clinical trial studies the following conditions: Sensorineural Hearing Loss, Bilateral Hearing Loss.
What interventions are being tested in trial NCT06936449?
The interventions under investigation include: CI632D (DEVICE), CI632 (DEVICE).
Who is sponsoring clinical trial NCT06936449?
This trial is sponsored by Cochlear, which has 34 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT06936449 being conducted?
This trial has 3 study locations across Colorado, Iowa, Ohio. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Sensorineural Hearing Loss
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT06936449's enrollment target sits among peer trials
19 12th of 13 higher than 2 of 13 other Sensorineural Hearing Loss trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Sensorineural Hearing Loss trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Perceptual Adaptation Following Cochlear Implantation (Aim 3a)
RECRUITING · NA
-
Quantification of Visually Evoked Cortical Potentials in Individuals With Hearing Loss
RECRUITING
-
Effects of Clear Speech on Listening Effort and Memory in Sentence Processing
RECRUITING · NA
-
Long-Term Outcomes of Children With Congenital CMV in New York State
RECRUITING
-
Social Influences on Sensorimotor Integration of Speech Production and Perception During Early Vocal Learning
RECRUITING · NA
-
Randomized Controlled Trial of Valganciclovir for Cytomegalovirus Infected Hearing Impaired Infants
ACTIVE NOT RECRUITING · Phase 2
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT03207464 · 19 participants · Phase 1
Molecular Imaging of NET Using [C-11]MRB-PET in MS
- NCT04318717 · 19 participants · Phase 2
Pembrolizumab and Hypofractionated Radiation Therapy for the Treatment of Mucosal Melanoma
- NCT05103904 · 19 participants · Phase 2
Lenvatinib for the Treatment of Recurrent Hepatocellular Carcinoma After Liver Transplant
- NCT05607407 · 19 participants · Phase 2
Methimazole in Patients With Progressive Glioblastoma
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI